• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对德系犹太人的携带者筛查套餐:越多越好吗?

Carrier screening panels for Ashkenazi Jews: is more better?

作者信息

Leib Jennifer R, Gollust Sarah E, Hull Sara Chandros, Wilfond Benjamin S

机构信息

Neurogenetics Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1156, USA.

出版信息

Genet Med. 2005 Mar;7(3):185-90. doi: 10.1097/01.gim.0000156527.87525.8f.

DOI:10.1097/01.gim.0000156527.87525.8f
PMID:15775754
Abstract

PURPOSE

To describe the characteristics of Ashkenazi Jewish carrier testing panels offered by US Laboratories, including what diseases are included, the labels used to describe the panels, and the prices of individual tests compared to the prices of panels for each laboratory.

METHODS

GeneTests (http://www.genetests.org) was searched for laboratories that offered Tay-Sachs disease testing. Information was obtained from laboratory web sites, printed brochures, and telephone calls about tests/panels.

RESULTS

Twenty-seven laboratories offered up to 10 tests. The tests included two diseases associated with death in childhood (Niemann-Pick type A and Tay-Sachs disease), five with moderate disability and a variably shortened life span (Bloom syndrome, Canavan disease, cystic fibrosis, familial dysautonomia, Fanconi anemia, and mucolipidosis type IV), and two diseases that are not necessarily disabling or routinely shorten the lifespan (Gaucher disease type I and DFNB1 sensorineural hearing loss). Twenty laboratories offered a total of 27 panels of tests for three to nine diseases, ranging in price from $200 to $2082. Of these, 15 panels cost less than tests ordered individually. The panels were described by 24 different labels; eight included the phrase Ashkenazi Jewish Disease or disorder and six included the phrase Ashkenazi Jewish Carrier.

CONCLUSION

There is considerable variability in the diseases, prices, and labels of panels. Policy guidance for establishing appropriate criteria for inclusion in panels may be useful to the Ashkenazi Jewish community, clinicians, and payers. Pricing strategies that offer financial incentives for the use of "more tests" should be reexamined.

摘要

目的

描述美国实验室提供的阿什肯纳兹犹太人群携带者检测套餐的特点,包括所涵盖的疾病、用于描述套餐的标签,以及各实验室单项检测价格与套餐价格的比较。

方法

在基因检测网站(http://www.genetests.org)搜索提供泰-萨克斯病检测的实验室。通过实验室网站、印刷手册及电话获取有关检测/套餐的信息。

结果

27家实验室提供多达10项检测。这些检测包括两种与儿童期死亡相关的疾病(A型尼曼-匹克病和泰-萨克斯病)、五种导致中度残疾且寿命不同程度缩短的疾病(布卢姆综合征、卡纳万病、囊性纤维化、家族性自主神经功能障碍、范可尼贫血和IV型黏脂贮积症),以及两种不一定导致残疾或常规缩短寿命的疾病(I型戈谢病和DFNB1感音神经性听力损失)。20家实验室提供了总共27种针对三至九种疾病的检测套餐,价格从200美元到2082美元不等。其中,15种套餐的费用低于单独订购检测项目的费用。这些套餐有24种不同的标签描述;其中8种包含“阿什肯纳兹犹太疾病或病症”短语,6种包含“阿什肯纳兹犹太携带者”短语。

结论

套餐在疾病、价格和标签方面存在很大差异。为阿什肯纳兹犹太人群体、临床医生和付款方制定纳入套餐的适当标准的政策指导可能会有所帮助。应重新审视为使用“更多检测项目”提供经济激励的定价策略。

相似文献

1
Carrier screening panels for Ashkenazi Jews: is more better?针对德系犹太人的携带者筛查套餐:越多越好吗?
Genet Med. 2005 Mar;7(3):185-90. doi: 10.1097/01.gim.0000156527.87525.8f.
2
Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.对阿什肯纳兹犹太人群进行囊性纤维化、戈谢病和泰-萨克斯病的携带者筛查:纽约大学医学中心(位于纽约州纽约市)的前1000例病例
Arch Intern Med. 1998 Apr 13;158(7):777-81. doi: 10.1001/archinte.158.7.777.
3
Selected genetic disorders affecting Ashkenazi Jewish families.影响阿什肯纳兹犹太家庭的特定遗传疾病。
Fam Community Health. 2007 Jan-Mar;30(1):50-62. doi: 10.1097/00003727-200701000-00007.
4
ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent.美国妇产科医师学会委员会意见。第298号,2004年8月。东欧犹太裔个体遗传性疾病的产前和孕前携带者筛查。
Obstet Gynecol. 2004 Aug;104(2):425-8. doi: 10.1097/00006250-200408000-00050.
5
The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.在巴西犹太人群体中,导致泰-萨克斯病的突变频率证明了开展携带者筛查项目的合理性。
Sao Paulo Med J. 2001 Jul 5;119(4):146-9. doi: 10.1590/s1516-31802001000400007.
6
Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent.用于检测常见于阿什肯纳兹犹太人血统人群遗传疾病的基因组 DNA 参考材料的开发。
J Mol Diagn. 2009 Nov;11(6):530-6. doi: 10.2353/jmoldx.2009.090050. Epub 2009 Oct 8.
7
ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent.美国妇产科医师学会第442号委员会意见:东欧犹太裔个体遗传性疾病的孕前和产前携带者筛查
Obstet Gynecol. 2009 Oct;114(4):950. doi: 10.1097/AOG.0b013e3181bd12f4.
8
Ashkenazi Jewish genetic disorders.阿什肯纳兹犹太人的遗传疾病。
Fam Cancer. 2004;3(3-4):201-6. doi: 10.1007/s10689-004-9545-z.
9
Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.通过突变分析对阿什肯纳兹犹太人中常见疾病进行特定人群筛查。
Hum Mutat. 1996;8(2):116-25. doi: 10.1002/(SICI)1098-1004(1996)8:2<116::AID-HUMU3>3.0.CO;2-9.
10
Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.基因专利和授权实践对塔-萨克斯病和卡纳万病遗传检测和携带者筛查获取的影响。
Genet Med. 2010 Apr;12(4 Suppl):S5-S14. doi: 10.1097/GIM.0b013e3181d5a669.

引用本文的文献

1
Burden of rare genetic disorders in India: twenty-two years' experience of a tertiary centre.印度罕见遗传疾病的负担:一家三级中心的二十二年经验。
Orphanet J Rare Dis. 2024 Aug 13;19(1):295. doi: 10.1186/s13023-024-03300-z.
2
Choices, attitudes, and experiences of genetic screening in Latino/a and Ashkenazi Jewish individuals.拉丁裔和阿什肯纳兹犹太个体在基因筛查方面的选择、态度及经历。
J Community Genet. 2020 Oct;11(4):391-403. doi: 10.1007/s12687-020-00464-6. Epub 2020 May 7.
3
Coming to terms with the imperfectly normal child: attitudes of Israeli parents of screen-positive infants regarding subsequent prenatal diagnosis.
接纳不那么正常的孩子:以色列筛查呈阳性婴儿的父母对后续产前诊断的态度。
J Community Genet. 2019 Jan;10(1):41-50. doi: 10.1007/s12687-018-0361-9. Epub 2018 Mar 5.
4
Responsible implementation of expanded carrier screening.负责开展扩大的携带者筛查。
Eur J Hum Genet. 2016 Jun;24(6):e1-e12. doi: 10.1038/ejhg.2015.271. Epub 2016 Mar 16.
5
Generating a taxonomy for genetic conditions relevant to reproductive planning.生成与生殖规划相关的遗传病症分类法。
Am J Med Genet A. 2016 Mar;170(3):565-73. doi: 10.1002/ajmg.a.37513.
6
Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?犹太社区的人们更喜欢基于血统的还是泛族裔的扩大携带者筛查?
Eur J Hum Genet. 2016 Feb;24(2):171-7. doi: 10.1038/ejhg.2015.97. Epub 2015 May 13.
7
Expanded carrier screening in reproductive healthcare: perspectives from genetics professionals.生殖保健中的扩展携带者筛查:遗传学专业人士的观点。
Hum Reprod. 2013 Jun;28(6):1725-30. doi: 10.1093/humrep/det091. Epub 2013 Apr 14.
8
Prenatal whole genome sequencing: just because we can, should we?产前全基因组测序:仅仅因为我们能够做到,我们就应该这样做吗?
Hastings Cent Rep. 2012 Jul-Aug;42(4):28-40. doi: 10.1002/hast.50. Epub 2012 Jun 20.
9
Prenatal healthcare providers' Gaucher disease carrier screening practices.产前保健提供者的戈谢病携带者筛查实践。
Genet Med. 2012 Oct;14(10):844-51. doi: 10.1038/gim.2012.63. Epub 2012 May 31.
10
Preconceptional genetic carrier testing and the commercial offer directly-to-consumers.孕前遗传携带者检测与直接面向消费者的商业服务。
Hum Reprod. 2011 May;26(5):972-7. doi: 10.1093/humrep/der042. Epub 2011 Feb 28.